Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Singh Inder MDirector | Grant or award | A | $6,593 122 sh | Oct 23, 2026 |
| 9 | Stillwell Mary-LeeSVP and Controller | Grant or award | A | $585 45 sh | Oct 23, 2026 traded Oct 22, 2026 |
| 8 | Pershing EdwardDirector, CEO, 10% Owner | Option exercise | M | — | Oct 23, 2026 traded Oct 23, 2026 |
| 8 | Borgeson John A.Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $187K 2,000 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 8 | Borgeson John A.Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $185K 2,000 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 8 | Gheuens SarahChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $56K 1,489 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 8 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $29K 120 sh | Oct 23, 2026 traded Oct 22, 2026 |
| 8 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $46K 194 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 8 | Borgeson John A.Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $150K 1,677 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 8 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $18K 80 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 6 | Borgeson John A.Chief Financial Officer | Option exercise · 10b5-1 plan | M | $75K 30.0K sh | Oct 23, 2026 traded Oct 21, 2026 |
| 6 | Honeycutt JenniferDirector, President and CEO | Option exercise · 10b5-1 plan | M | $204K 7,098 sh | Oct 23, 2026 traded Oct 23, 2026 |
| 5 | rahim ramiEVP, Pres GM Networking | Grant or award · 10b5-1 plan | A | — 579 sh | Oct 23, 2026 traded Oct 16, 2026 |
| 5 | rahim ramiEVP, Pres GM Networking | Grant or award · 10b5-1 plan | A | — 252 sh | Oct 23, 2026 traded Oct 16, 2026 |
| 5 | Borgeson John A.Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $9,491 100 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 5 | Lentz DanielCFO & COO | Tax withholding | F | $6,241 1,724 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 4 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | Option exercise · 10b5-1 plan | M | — 15.3K sh | Oct 23, 2026 traded Oct 21, 2026 |
| 4 | Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 34.4K sh | Oct 23, 2026 traded Oct 22, 2026 |
| 4 | Rogers Daniel MarkDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $227K 19.7K sh | Oct 23, 2026 traded Oct 22, 2026 |
| 4 | Ashish AroraDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $379K 60.0K sh | Oct 23, 2026 traded Oct 22, 2026 |
| 4 | Ashish AroraDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $379K 60.0K sh | Oct 23, 2026 traded Oct 21, 2026 |
| 4 | Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | Option exercise · 10b5-1 plan | M | — 21.9K sh | Oct 23, 2026 traded Oct 22, 2026 |
| 4 | Sarowitz Steven IDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $463K 2,728 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 4 | Sarowitz Steven IDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $267K 1,564 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 4 | Ashish AroraDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $376K 60.0K sh | Oct 23, 2026 traded Oct 23, 2026 |
| 3 | Borgeson John A.Chief Financial Officer | Option exercise · 10b5-1 plan | M | — 30.0K sh | Oct 23, 2026 traded Oct 21, 2026 |
| 3 | Gheuens SarahChief Medical Officer | Option exercise · 10b5-1 plan | M | — 1,489 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 2 | Malady KyleEVP and Group CEO-VZ Business | Grant or award | A | $1,738 135 sh | Oct 23, 2026 traded Oct 22, 2026 |
| 1 | Sarowitz Steven IDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $154K 900 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 1 | Sarowitz Steven IDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $93K 552 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 1 | Gheuens SarahChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $19K 500 sh | Oct 23, 2026 traded Oct 22, 2026 |
| 0 | Fox-Geen JeremyChief Financial Officer | Option exercise · 10b5-1 plan | M | $152K 15.0K sh | Oct 23, 2026 traded Oct 21, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 6,573 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 0 | Gheuens SarahChief Medical Officer | Option exercise · 10b5-1 plan | M | $13K 500 sh | Oct 23, 2026 traded Oct 22, 2026 |
| 0 | Gheuens SarahChief Medical Officer | Option exercise · 10b5-1 plan | M | $37K 1,489 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 0 | Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | Option exercise · 10b5-1 plan | M | $47K 21.9K sh | Oct 23, 2026 traded Oct 22, 2026 |
| 0 | Bhatt BaijuDirector | Derivative conversion · 10b5-1 plan | C | — 50.9K sh | Oct 23, 2026 traded Oct 21, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 6,573 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | Option exercise · 10b5-1 plan | M | — 21.4K sh | Oct 23, 2026 traded Oct 21, 2026 |
| 0 | Robinhood Markets, Inc.10% Owner | Open-market sale · 10b5-1 plan | SELL | $2,126 85 sh | Oct 23, 2026 traded Oct 21, 2026 |